Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Subject
Anesthesiology and Pain Medicine,General Medicine
Reference17 articles.
1. Rosenberg H, Sambuughin N, Riazi S, Dirksen R. Malignant Hyperthermia Susceptibility. In: Adam MP, Ardinger HH, Pagon RA, et al. (Eds). GeneReviews®. Seattle (WA): University of Washington, Seattle; 2020. Available from URL: https://www.ncbi.nlm.nih.gov/books/NBK1146/ (accessed October 2021).
2. Butala B, Busada M, Cormican D. Malignant hyperthermia: review of diagnosis and treatment during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2018; 32: 2771-9.
3. Silva HC, Ferreira G, Rodrigues G, et al. Profile of malignant hyperthermia susceptibility reports confirmed with muscular contracture test in Brazil (Portuguese). Braz J Anestesiol 2019; 69: 152-9.
4. Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5.
5. Anonymous. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. Br J Anaesth 1984; 56: 1267-9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multiple drugs;Reactions Weekly;2022-01